MiraLAX Launch, Claritin Drive Schering-Plough Consumer Sales
This article was originally published in The Tan Sheet
Executive Summary
An increase in OTC Claritin salesand the introduction of the laxative MiraLAX during 2007 helped drive up Schering-Plough's consumer health care sales 24 percent to $254 million in its fourth quarter, the Kenilworth, N.J.-based firm said during a Feb. 12 earnings call